ObesityNCT03528044
Emotional Regulation, Cognition, Impulsivity and Reward System in Obesity: A Prospective Study of Bariatric Surgery
A study testing Bariatric surgery in people with Obesity and Cognitive Disorder, run by Koç University at 3 sites in Turkey (Türkiye).
Trial summary
This research investigates obesity and associated psychiatric symptoms and disorders in a wide range of perspectives, to demonstrate the effects of obesity on the brain. The 1st aim is to assess the psychiatric symptom profiles in the group of obese patients applying for bariatric surgery and to determine the… Read more about this study
- Who is it for?
- Ages 18 to 65 yearsHealthy volunteers can take part
- Conditions the study is for
- Obesity, Cognitive Disorder
- What is being tested?
- Bariatric surgery
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 50 participants
- Where
- 3 sitesTurkey (Türkiye)
- Study dates
- 6 Jun 2017to 6 Jun 2022
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Be between the ages of 18-65
- To be able to give informed consent
- Be a candidate for bariatric surgery.
- Be between the ages of 18-65
- To be able to give informed consent
- To be in normal range for BMI
- To be observed as in the normal mental status examination
Who cannot join
- Dementia
- Individuals with severe mental retardation and marked cognitive impairments
- Psychotic disorders
- Psychoactive substance addiction diagnosis
- For healthy volunteers:
- Dementia
Show all 9Show fewer
- Individuals with severe mental retardation and marked cognitive impairments
- Psychotic disorders
- Psychoactive substance addiction diagnosis
Trial locations and contacts
3 sites in 1 country.
Turkey (Türkiye)3 sites
Fatih Sultan Mehmed Training and Research Hospital
Istanbul
Koc University School of Medicine
Istanbul
Marmara University Pendik Training and Research Hospital
Istanbul
About this study
Official title: Evaluation and Follow up of Emotional Regulation, Cognition, Impulsivity and Reward System in Obesity, and Determination of Its Biopsychosocial Risk Factors: A Prospective Study of Obese Patients Before and After Bariatric Surgery
This research investigates obesity and associated psychiatric symptoms and disorders in a wide range of perspectives, to demonstrate the effects of obesity on the brain. The 1st aim is to assess the psychiatric symptom profiles in the group of obese patients applying for bariatric surgery and to determine the associated environmental stress factors. While, it is known that eating disorders, mood disorders and psychiatric drugs can cause obesity, obesity can also cause many psychiatric complications such as depression and cognitive disorders. There are no multi-centered studies that are conducted in this respect, and the guidelines on pre-evaluation and follow-up of patients are also lacking. The 2nd aim is to evaluate and monitor cognitive characteristics before and after bariatric surgery in obese patients. Obese people are at increased risk of dementia and are more likely to have cognitive deficits, especially executive function problems, that can affect everyday life. For this reason, obese individuals should be examined and monitored in more detail in terms of their cognitive characteristics and the change of cognitive functions during the weight loss process. The 3rd aim is to examine the relationship between obesity, bariatric surgery and reward processing system. Studies have been limited in determining whether addiction in these people is due to a search of a continuous substance as a cognitive feature or whether it is difficult to terminate it as an impulsive behavior when encountered with a pleasurable substance, even though there is no reward seeking or reward dependence. The 4th aim is the determination of the neuroanatomical and molecular components of cognitive changes observed after bariatric surgery. During the dynamic process following bariatric surgery, a variety of metabolites, chemokines, and microbiota changes may also affect the brain health and cognition. The 5th aim is to determine factors of eating, emotional regulation, reward system, addiction and impulsivity, and other psychopathologies that cause suboptimal weight loss or weight gain after bariatric surgery. Understanding the psychological and neurobiological factors involved in these processes can improve surgical interventions and significantly increase the quality of life for patients.
Read the detailed description
Aim 1: To assess the psychiatric symptom profiles in the group of obese patient candidates applying for bariatric surgery and to determine the associated environmental stress factors.
Patients will be evaluated with psychosocial scales as part of their pre-surgery assessments. The first psychosocial evaluation of the patients will be performed by a structured clinical interview (SCID) by Dr. Hale Yapici Eser, Dr. Özge Kılıç and then, the participants will be asked to fill in the self-assessment scales and they will be applied some computer based cognitive tests via the assistance of Candan Yasemin Eren.
Scales used to model environmental factors:
- Sociodemographic Data Form
- Childhood Trauma Questionnaire
- Chronic Stress Scale
- Perceived Stress Scale
- Distress Thermometer
- Multidimensional Scale of Perceived Social Support Scales used to evaluate psychiatric symptom profile:
- Beck Depression Scale
- Beck Anxiety Scale
- Barratt Impulsivity Scale
- Cognitive Failures Questionnaire
- Mood Disorder Questionnaire
- Yale Food Addiction Scale
- Relationship Scales Questionnaire
- Difficulties in Emotion Regulation Scale
- Snaith-Hamilton Pleasure Scale
Patients will fill these measurements using Qualtrics. The findings of the structured interview and results of the scale scores will be analyzed by SPSS. From these scales, evaluations other than scales 2 and 13 will be re-administered at the 3rd month and 12th months after bariatric surgery. Scale scores will be used for follow-up of patients.
Aim 2: To evaluate and monitor cognitive characteristics before and after bariatric surgery in obese patients.
The cognitive functions of the patients will be assessed, pre and post operationally (3rd and 12th months), by the Penn-CNP neuropsychological test battery and the 'Cognitive Failures Questionnaire' indicated as the 10th item above. 'Cognitive Failures Questionnaire' is a self-administered scale, which is aimed at questioning the different areas of cognition such as attention, memory and perception. Penn-CNP is a neuropsychological test battery developed by Prof. Dr. Rachel Gur at the University of Pennsylvania and already in use on large sampled and multi centered researches. The required tasks of this battery is translated into Turkish by establishing a connection between Dr. Hale Yapici Eser and these research centers.
The Penn-CNP neuropsychological test battery can assess cognitive features such as emotion recognition and discrimination, working memory, visual-spatial perception and memory, motor praxis, impulsivity and attention. Some of these tests are aimed at evaluating the effect of reaction time and motor capacity on test responses, while others investigate emotion recognition processes with different aspects of cognition such as attention, working and long-term memory, executive functions and visual-spatial perception.For each test applied with this battery, the test results are automatically calculated by the system and the response time, correct and incorrect answers for each response are also presented in an analytical data format. The program also does unbiased arithmetic calculations on important data for further analysis.
Test result tables of the battery can be reviewed in detail from the following link:
https://penncnp.med.upenn.edu/doc.pl?section=pi\&content=factsheets/penncnp_test_descriptions-v1.00.pdf
Cognitive scales will be repeated at 0, 3 and 12 months post-operation. These follow-ups have important implications. Findings obtained for each test will be monitored in terms of changes between pre and post operation. Also, the effects of the variables mentioned in method 4 will be analyzed on the scores obtained on each cognitive test by the SPSS program. In addition, test results will be compared in terms of the changes made in the measurements in the control group mentioned in method 4.
Aim 3: To examine the relationship between obesity, bariatric surgery and reward processing system.
The cognitive functions of the patients will be assessed with the "Probabilistic Reward Task (PRT)" pre and 3rd and 12th months after bariatric surgery to examine the changes in the reward learning systems after bariatric surgery.PRT is a signal detection task used for measuring hedonic capacity and reward learning based on monetary reward enhancement. Developed by Diego Pizzagalli in 2005, PRT is an objective assessment of the participants' tendency to modulate their behavior in relation to the prize. At each trial, subjects are asked to choose between two very similar stimuli. The stimuli consist of simple cartoon faces presented at the center of the monitor. Subjects are instructed to press on the appropriate button to determine whether the stimulus is presented with long (11 mm) or short (10 mm) mouth. One of the stimuli (the "rich stimulus") is awarded three times more often than the other ("lean") but the subjects do not know about it. The reward is presented with: "True! You have earned 25 cents". In healthy controls, this reinforcement method leads to response bias, and more frequent rewarding stimuli are preferred. The response bias towards the more frequently rewarded stimuli will be used to operationalize reward sensitivity. Due to participation and validity of the test participants will be given 20 TL independently from their performance. Mentioned evaluations will be repeated at 0, 3 and 12 months. Findings obtained for each test will be monitored in terms of changes between pre and post operation. Also, the effects of the variables mentioned in method 4 will be analyzed on the scores obtained on each cognitive test by the SPSS program.
Aim 4: Determination of the neuroanatomical and molecular components of cognitive changes observed after bariatric surgery.
In this part of the study, brain imaging and biochemical measurements will be conducted. Patients who have completed Method 1 will be evaluated on psychiatric examination and scale scores to be able to be eligible for this stage. During the preliminary evaluations, people with conditions that might affect their cognition and cause brain damage will not be included. Patients who meet the criteria will be exposed to the following measurements at pre-operative, 3 and 12 months. A second group of healthy volunteers with normal body mass index, paired with age, gender, education status and psychiatric assessment scale scores, with normal BMI, will be formed.
Imaging studies: Structural and functional changes in the brain will be evaluated by magnetic resonance imaging (MRI). Thin-section T1-weighted images for evaluation of gray matter changes, resting functional magnetic resonance images for evaluation of functional changes will be obtained. For resting fMRI, patients will be asked to rest eyes closed for 6 minutes without thinking anything. MRI examination will be repeated both for the obese patient group and concurrently healthy controls before surgery (0 months) and after surgery at 3 and 12 months. Imaging will take approximately 30 minutes.
All brain group analyzes of the structural imaging data obtained at the pre-operative, baseline, time point of the obese patient group and the healthy control group will be performed and the brain regions in the obese patient group will be determined for the gray matter changes. The first stage analysis will focus on the brain areas where gray matter changes are observed, and these areas will be compared with the data obtained from the after bariatric surgery imaging sessions. For the evaluation of these changes, focus areas will be placed in the brain areas where obese individuals have gray matter changes, and detailed analysis will be made. Focused analysis and whole brain comparisons performed by placing the areas of interest as mentioned will be performed in comparison with longitudinal data (comparing baseline-3 and 12 months of obese individuals with each other) and normal healthy groups' 3 and 12 months data. In addition, structural changes in the brain will be analyzed in relation to cognitive functions, stress factors, and mood changes. For second stage analysis, interest areas will be placed to the prefrontal cortex, hippocampus, and temporal lobe and data of obese patient group and healthy controls will be compared at the baseline, 3rd and 12th months. In addition, a longitudinal analysis will be performed on the obese patient group (comparing 0-3 and 12 months of obese individuals with each other) to assess the effect of bariatric surgery on these brain areas.
In resting state fMRI, the focus now is to examine the functional connectivity changes in the ventral tegmental area as its activity correlates with reward learning and prefrontal cortex as the center for executive functions. Depending on the findings of the clinical data obtained from the study, different areas of interest will be identified and functional associations will be examined. Focused analyzes on areas of interest mentioned above will be performed both longitudinally (comparing 0-3 and 12 months of the obese individuals with each other) and 3 and 12 months comparisons between healthy controls and obese group. In addition, functional changes in the brain will be analyzed in relation to cognitive functions and mood changes.
Biological Analysis: Blood samples obtained will also be used to analyze peripheral biological markers that may be risk factors. Metabolic parameters, inflammatory markers, and GLP levels will be measured and recorded.
- Serum cortisol levels
- Serum GLP levels
- Ghrelin, leptin
- Calculation of HbA1C, glucose, insulin levels and HOMA IR
- Thyroid stimulating hormone (TSH) levels
- CRP levels
- Inflammatory panel (IL-1, IL-6 and TNF-a levels)
- B12, folic acid and ferritin levels
- Serum lipid profile (total cholesterol, LDL cholesterol, HDL cholesterol, triglyceride)
- Liver function tests
In addition to neuroanatomical and other biomarkers, investigating physicians will monitor the general clinical status of the patients and changes such as hypertension and sleep apnea will be noted. Nutritionists will also follow diet compliance of the patients. Daily mobility and exercise levels will also be assessed. All of these obtained markers will be used both longitudinally (0-3 and 12 months of obese individuals compared to each other) and comparison to healthy controls at the 0, 3 and 12 months. During the collection of imaging and biomarkers data, the control group will be monitored for 12 months as well.
Aim 5: To determine factors of eating, emotional regulation, reward system, addiction and impulsivity, and other psychopathologies that cause suboptimal weight loss or weight gain after bariatric surgery.
Similar to the previous methods, patients will fill in the self-assessment scales and apply cognitive tests on the computer via the assistance of Candan Yasemin Eren. The tests to be applied in this section will be the scales used to evaluate the environmental and psychiatric profile described in method 1, the PENN-CNP battery described in method 2, and the PRT batteries in method 3.
- Conditions
- Obesity, Cognitive Disorder
- Being tested
- Bariatric surgery
- Keywords
- Bariatric surgery, Reward, Cognition, Working memory, Grey matter, GLP-1, Inflammation, Stress, Follow-up, Psychiatric
- Medical subject headings
- Obesity, Cognitive Dysfunction, Inflammation
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Bariatric surgeryProcedure or surgery
In this study, patients will undergo sleeve gastrectomy to reduce the size of the stomach to induce weight loss.
| Study group | Role | What they receive |
|---|---|---|
| Patients undergoing bariatric surgery | Experimental | In this study, patients will undergo sleeve gastrectomy to reduce the size of the stomach to induce weight loss. Receives: Procedure: Bariatric surgery |
| Control group | No intervention | Healthy controls with normal BMI. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Changes in working memory following bariatric surgery
Letter-and-Back Task in the PENN-CNP neuropsychological battery will be used to assess working memory. Letter-and-Back asks participants to focus on letters on the screen and press the spacebar according to certain rules. The task consists of three parts: 0-back, 1-back, 2-back. During 0-back, participants press the spacebar when they see letter "X" on the screen. During 1-back, participants press the spacebar when they see the same letter twice. During 2-back, participants press the spacebar when the letter on the screen is the same as the letter before the previous letter.
Measured: Pre-surgery, 3rd and 12th months after bariatric surgery
Grey-matter changes in the entire brain, focused assessments on brain areas known to be associated with cognitive functions
Structural and functional changes in the brain will be evaluated by magnetic resonance imaging (MRI). Thin-section T1-weighted images for evaluation of gray matter changes, resting functional magnetic resonance images for evaluation of functional changes will be obtained. For resting fMRI, patients will be asked to rest eyes closed for 6 minutes without thinking anything. Imaging will take approximately 30 minutes.
Measured: MRI examination will be repeated both for the obese patient group and concurrently healthy controls before surgery (0 months) and after surgery at 3 and 12 months.
Secondary outcomes (6)
Changes in impulsivity following bariatric surgery
Continuous performance task in the PENN-CNP neuropsychological battery and Barratt Impulsivity Scale will be used to assess impulsivity. While continuous performance task assess impulsivity by a computer-based task, Baratt Impulsivity measure is a self-report measure. Therefore, both methods are significant in assessment of impulsivity.
Measured: Pre-surgery, 3rd and 12th months after bariatric surgery
Success of surgery
Percentage of weight loss proportional to baseline weight measurements
Measured: 3rd and 12th months after bariatric surgery
Changes in inflammator factors following bariatric surgery
Blood samples will be obtained from patients to analyze inflammatory markers such as IL-1, IL-6 and TNF-a levels.
Measured: Pre-surgery, 3rd and 12th months after bariatric surgery
Changes in GLP1 will be analyzed following bariatric surgery
Blood samples will be obtained from patients to analyze GLP1 levels.
Measured: Pre-surgery, 3rd and 12th months after bariatric surgery
Changes in social cognition following bariatric surgery
Emotion Recognition Task in the PENN-CNP neuropsychological battery will be used to assess social cognition. Participants see series of 40 faces and are asked to determine the emotion the faces are showing in each trial. There are five different choices: happy, sad, anger, fear and no emotion. The scoring is based on the number of correct responses for each emotion and the number of correctly identified mild and intense emotion expressions. Median response times are also calculated.
Measured: Pre-surgery, 3rd and 12th months after bariatric surgery
Changes in reward learning following bariatric surgery
PRT is used to examine the changes in the reward learning systems after bariatric surgery. It is a signal detection task used for measuring hedonic capacity and reward learning based on monetary reward enhancement. PRT is an objective assessment of the participants' tendency to modulate their behavior in relation to the prize.
Measured: Pre-surgery, 3rd and 12th months after bariatric surgery
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 May 2018
- Study start6 Jun 2017
- Primary completion6 Jun 2022
- Study completion6 Jun 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (85)Papers the sponsor has linked to this study.
- Other trials for ObesityStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Basic science
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Model description
- In this study, patients undergoing bariatric surgery will be assessed at baseline and after bariatric surgery. We intend to analyze the changes in this repeated and dependent measurements. The other group will be undisturbed during the follow up except for clinical assessments and MRI imaging.
- Masking
- None (open label)
- Enrolment
- 50 participants (actual)
Sponsor and investigators
- Lead sponsor
- Koç University
- Sponsor type
- University, hospital or other
- Collaborators
- Fatih Sultan Mehmet Training and Research Hospital, Marmara University
- Responsible party
- Sponsor
- Investigators
- Hale Yapici Eser, MD, PHD, Principal investigator, Koc University School of Medicine
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03528044
- Sponsor's protocol ID
- KocU Bari
- Other IDs
- 2017.081.IRB1.011
- Status last verified
- Sep 2023
- First submitted
- 19 Mar 2018
- Last updated
- 5 Oct 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Admon R, Pizzagalli DA. Dysfunctional Reward Processing in Depression. Curr Opin Psychol. 2015 Aug 1;4:114-118. doi: 10.1016/j.copsyc.2014.12.011.
PubMed 26258159Alciati A, Gesuele F, Rizzi A, Sarzi-Puttini P, Foschi D. Childhood parental loss and bipolar spectrum in obese bariatric surgery candidates. Int J Psychiatry Med. 2011;41(2):155-71. doi: 10.2190/PM.41.2.e.
PubMed 21675347Zeki Al Hazzouri A, Haan MN, Whitmer RA, Yaffe K, Neuhaus J. Central obesity, leptin and cognitive decline: the Sacramento Area Latino Study on Aging. Dement Geriatr Cogn Disord. 2012;33(6):400-9. doi: 10.1159/000339957. Epub 2012 Jul 17.
PubMed 22814127Alosco ML, Spitznagel MB, Strain G, Devlin M, Cohen R, Crosby RD, Mitchell JE, Gunstad J. Improved serum leptin and ghrelin following bariatric surgery predict better postoperative cognitive function. J Clin Neurol. 2015 Jan;11(1):48-56. doi: 10.3988/jcn.2015.11.1.48. Epub 2015 Jan 2.
PubMed 25628737Alosco ML, Spitznagel MB, Strain G, Devlin M, Cohen R, Paul R, Crosby RD, Mitchell JE, Gunstad J. Improved memory function two years after bariatric surgery. Obesity (Silver Spring). 2014 Jan;22(1):32-8. doi: 10.1002/oby.20494. Epub 2013 Oct 15.
PubMed 23625587Anstey KJ, Cherbuin N, Budge M, Young J. Body mass index in midlife and late-life as a risk factor for dementia: a meta-analysis of prospective studies. Obes Rev. 2011 May;12(5):e426-37. doi: 10.1111/j.1467-789X.2010.00825.x. Epub 2011 Feb 23.
PubMed 21348917Bak M, Seibold-Simpson SM, Darling R. The potential for cross-addiction in post-bariatric surgery patients: Considerations for primary care nurse practitioners. J Am Assoc Nurse Pract. 2016 Dec;28(12):675-682. doi: 10.1002/2327-6924.12390. Epub 2016 Jul 11.
PubMed 27400415Bellinger FP, Madamba SG, Campbell IL, Siggins GR. Reduced long-term potentiation in the dentate gyrus of transgenic mice with cerebral overexpression of interleukin-6. Neurosci Lett. 1995 Sep 29;198(2):95-8. doi: 10.1016/0304-3940(95)11976-4.
PubMed 8592650Bergmann KL, Cox SJ, Tabone LE. Influence of a rural environment on patient access and outcomes for bariatric surgery. Surg Obes Relat Dis. 2017 Apr;13(4):632-636. doi: 10.1016/j.soard.2016.11.009. Epub 2016 Nov 11.
PubMed 28159563Biessels GJ, Deary IJ, Ryan CM. Cognition and diabetes: a lifespan perspective. Lancet Neurol. 2008 Feb;7(2):184-90. doi: 10.1016/S1474-4422(08)70021-8.
PubMed 18207116Bjorntorp P. Do stress reactions cause abdominal obesity and comorbidities? Obes Rev. 2001 May;2(2):73-86. doi: 10.1046/j.1467-789x.2001.00027.x.
PubMed 12119665Blum K, Bailey J, Gonzalez AM, Oscar-Berman M, Liu Y, Giordano J, Braverman E, Gold M. Neuro-Genetics of Reward Deficiency Syndrome (RDS) as the Root Cause of "Addiction Transfer": A New Phenomenon Common after Bariatric Surgery. J Genet Syndr Gene Ther. 2011 Dec 23;2012(1):S2-001. doi: 10.4172/2157-7412.S2-001.
PubMed 23483116Bordignon S, Aparicio MJG, Bertoletti J, Trentini CM. Personality characteristics and bariatric surgery outcomes: a systematic review. Trends Psychiatry Psychother. 2017 Apr-Jun;39(2):124-134. doi: 10.1590/2237-6089-2016-0016. Epub 2017 Jun 12.
PubMed 28614435Cunningham AJ, Murray CA, O'Neill LA, Lynch MA, O'Connor JJ. Interleukin-1 beta (IL-1 beta) and tumour necrosis factor (TNF) inhibit long-term potentiation in the rat dentate gyrus in vitro. Neurosci Lett. 1996 Jan 12;203(1):17-20. doi: 10.1016/0304-3940(95)12252-4.
PubMed 8742036Debette S, Seshadri S, Beiser A, Au R, Himali JJ, Palumbo C, Wolf PA, DeCarli C. Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline. Neurology. 2011 Aug 2;77(5):461-8. doi: 10.1212/WNL.0b013e318227b227.
PubMed 21810696
Study at a glance
From the registry record, last updated by the sponsor on 5 Oct 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluation and Follow up of Emotional Regulation, Cognition, Impulsivity and Reward System in Obesity, and Determination of Its Biopsychosocial Risk Factors: A Prospective Study of Obese Patients Before and After Bariatric Surgery
- ClinicalTrials.gov ID
- NCT03528044
- Acronym / sponsor ID
- KocU Bari
- Conditions
- Obesity, Cognitive Disorder
- Keywords
- Bariatric surgery, Reward, Cognition, Working memory, Grey matter, GLP-1, Inflammation, Stress
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 50 participants (actual)
- Lead sponsor
- Koç UniversityUniversity, hospital or other
- Collaborators
- Fatih Sultan Mehmet Training and Research Hospital, Marmara University
- Study start
- 6 Jun 2017 (actual)
- Primary completion
- 6 Jun 2022 (actual)
- Study completion
- 6 Jun 2022 (actual)
- First posted
- 17 May 2018 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This research investigates obesity and associated psychiatric symptoms and disorders in a wide range of perspectives, to demonstrate the effects of obesity on the brain. The 1st aim is to assess the psychiatric symptom profiles in the group of obese patients applying for bariatric surgery and to determine the associated environmental stress factors. While, it is known that eating disorders, mood disorders and psychiatric drugs can cause obesity, obesity can also cause many psychiatric complications such as depression and cognitive disorders. There are no multi-centered studies that are conducted in this respect, and the guidelines on pre-evaluation and follow-up of patients are also lacking. The 2nd aim is to evaluate and monitor cognitive characteristics before and after bariatric surgery in obese patients. Obese people are at increased risk of dementia and are more likely to have cognitive deficits, especially executive function problems, that can affect everyday life. For this reason, obese individuals should be examined and monitored in more detail in terms of their cognitive characteristics and the change of cognitive functions during the weight loss process. The 3rd aim is to examine the relationship between obesity, bariatric surgery and reward processing system. Studies have been limited in determining whether addiction in these people is due to a search of a continuous substance as a cognitive feature or whether it is difficult to terminate it as an impulsive behavior when encountered with a pleasurable substance, even though there is no reward seeking or reward dependence. The 4th aim is the determination of the neuroanatomical and molecular components of cognitive changes observed after bariatric surgery. During the dynamic process following bariatric surgery, a variety of metabolites, chemokines, and microbiota changes may also affect the brain health and cognition. The 5th aim is to determine factors of eating, emotional regulation, reward system, addiction and impulsivity, and other psychopathologies that cause suboptimal weight loss or weight gain after bariatric surgery. Understanding the psychological and neurobiological factors involved in these processes can improve surgical interventions and significantly increase the quality of life for patients.
Detailed description
Aim 1: To assess the psychiatric symptom profiles in the group of obese patient candidates applying for bariatric surgery and to determine the associated environmental stress factors.
Patients will be evaluated with psychosocial scales as part of their pre-surgery assessments. The first psychosocial evaluation of the patients will be performed by a structured clinical interview (SCID) by Dr. Hale Yapici Eser, Dr. Özge Kılıç and then, the participants will be asked to fill in the self-assessment scales and they will be applied some computer based cognitive tests via the assistance of Candan Yasemin Eren.
Scales used to model environmental factors:
- Sociodemographic Data Form
- Childhood Trauma Questionnaire
- Chronic Stress Scale
- Perceived Stress Scale
- Distress Thermometer
- Multidimensional Scale of Perceived Social Support Scales used to evaluate psychiatric symptom profile:
- Beck Depression Scale
- Beck Anxiety Scale
- Barratt Impulsivity Scale
- Cognitive Failures Questionnaire
- Mood Disorder Questionnaire
- Yale Food Addiction Scale
- Relationship Scales Questionnaire
- Difficulties in Emotion Regulation Scale
- Snaith-Hamilton Pleasure Scale
Patients will fill these measurements using Qualtrics. The findings of the structured interview and results of the scale scores will be analyzed by SPSS. From these scales, evaluations other than scales 2 and 13 will be re-administered at the 3rd month and 12th months after bariatric surgery. Scale scores will be used for follow-up of patients.
Aim 2: To evaluate and monitor cognitive characteristics before and after bariatric surgery in obese patients.
The cognitive functions of the patients will be assessed, pre and post operationally (3rd and 12th months), by the Penn-CNP neuropsychological test battery and the 'Cognitive Failures Questionnaire' indicated as the 10th item above. 'Cognitive Failures Questionnaire' is a self-administered scale, which is aimed at questioning the different areas of cognition such as attention, memory and perception. Penn-CNP is a neuropsychological test battery developed by Prof. Dr. Rachel Gur at the University of Pennsylvania and already in use on large sampled and multi centered researches. The required tasks of this battery is translated into Turkish by establishing a connection between Dr. Hale Yapici Eser and these research centers.
The Penn-CNP neuropsychological test battery can assess cognitive features such as emotion recognition and discrimination, working memory, visual-spatial perception and memory, motor praxis, impulsivity and attention. Some of these tests are aimed at evaluating the effect of reaction time and motor capacity on test responses, while others investigate emotion recognition processes with different aspects of cognition such as attention, working and long-term memory, executive functions and visual-spatial perception.For each test applied with this battery, the test results are automatically calculated by the system and the response time, correct and incorrect answers for each response are also presented in an analytical data format. The program also does unbiased arithmetic calculations on important data for further analysis.
Test result tables of the battery can be reviewed in detail from the following link:
https://penncnp.med.upenn.edu/doc.pl?section=pi\&content=factsheets/penncnp_test_descriptions-v1.00.pdf
Cognitive scales will be repeated at 0, 3 and 12 months post-operation. These follow-ups have important implications. Findings obtained for each test will be monitored in terms of changes between pre and post operation. Also, the effects of the variables mentioned in method 4 will be analyzed on the scores obtained on each cognitive test by the SPSS program. In addition, test results will be compared in terms of the changes made in the measurements in the control group mentioned in method 4.
Aim 3: To examine the relationship between obesity, bariatric surgery and reward processing system.
The cognitive functions of the patients will be assessed with the "Probabilistic Reward Task (PRT)" pre and 3rd and 12th months after bariatric surgery to examine the changes in the reward learning systems after bariatric surgery.PRT is a signal detection task used for measuring hedonic capacity and reward learning based on monetary reward enhancement. Developed by Diego Pizzagalli in 2005, PRT is an objective assessment of the participants' tendency to modulate their behavior in relation to the prize. At each trial, subjects are asked to choose between two very similar stimuli. The stimuli consist of simple cartoon faces presented at the center of the monitor. Subjects are instructed to press on the appropriate button to determine whether the stimulus is presented with long (11 mm) or short (10 mm) mouth. One of the stimuli (the "rich stimulus") is awarded three times more often than the other ("lean") but the subjects do not know about it. The reward is presented with: "True! You have earned 25 cents". In healthy controls, this reinforcement method leads to response bias, and more frequent rewarding stimuli are preferred. The response bias towards the more frequently rewarded stimuli will be used to operationalize reward sensitivity. Due to participation and validity of the test participants will be given 20 TL independently from their performance. Mentioned evaluations will be repeated at 0, 3 and 12 months. Findings obtained for each test will be monitored in terms of changes between pre and post operation. Also, the effects of the variables mentioned in method 4 will be analyzed on the scores obtained on each cognitive test by the SPSS program.
Aim 4: Determination of the neuroanatomical and molecular components of cognitive changes observed after bariatric surgery.
In this part of the study, brain imaging and biochemical measurements will be conducted. Patients who have completed Method 1 will be evaluated on psychiatric examination and scale scores to be able to be eligible for this stage. During the preliminary evaluations, people with conditions that might affect their cognition and cause brain damage will not be included. Patients who meet the criteria will be exposed to the following measurements at pre-operative, 3 and 12 months. A second group of healthy volunteers with normal body mass index, paired with age, gender, education status and psychiatric assessment scale scores, with normal BMI, will be formed.
Imaging studies: Structural and functional changes in the brain will be evaluated by magnetic resonance imaging (MRI). Thin-section T1-weighted images for evaluation of gray matter changes, resting functional magnetic resonance images for evaluation of functional changes will be obtained. For resting fMRI, patients will be asked to rest eyes closed for 6 minutes without thinking anything. MRI examination will be repeated both for the obese patient group and concurrently healthy controls before surgery (0 months) and after surgery at 3 and 12 months. Imaging will take approximately 30 minutes.
All brain group analyzes of the structural imaging data obtained at the pre-operative, baseline, time point of the obese patient group and the healthy control group will be performed and the brain regions in the obese patient group will be determined for the gray matter changes. The first stage analysis will focus on the brain areas where gray matter changes are observed, and these areas will be compared with the data obtained from the after bariatric surgery imaging sessions. For the evaluation of these changes, focus areas will be placed in the brain areas where obese individuals have gray matter changes, and detailed analysis will be made. Focused analysis and whole brain comparisons performed by placing the areas of interest as mentioned will be performed in comparison with longitudinal data (comparing baseline-3 and 12 months of obese individuals with each other) and normal healthy groups' 3 and 12 months data. In addition, structural changes in the brain will be analyzed in relation to cognitive functions, stress factors, and mood changes. For second stage analysis, interest areas will be placed to the prefrontal cortex, hippocampus, and temporal lobe and data of obese patient group and healthy controls will be compared at the baseline, 3rd and 12th months. In addition, a longitudinal analysis will be performed on the obese patient group (comparing 0-3 and 12 months of obese individuals with each other) to assess the effect of bariatric surgery on these brain areas.
In resting state fMRI, the focus now is to examine the functional connectivity changes in the ventral tegmental area as its activity correlates with reward learning and prefrontal cortex as the center for executive functions. Depending on the findings of the clinical data obtained from the study, different areas of interest will be identified and functional associations will be examined. Focused analyzes on areas of interest mentioned above will be performed both longitudinally (comparing 0-3 and 12 months of the obese individuals with each other) and 3 and 12 months comparisons between healthy controls and obese group. In addition, functional changes in the brain will be analyzed in relation to cognitive functions and mood changes.
Biological Analysis: Blood samples obtained will also be used to analyze peripheral biological markers that may be risk factors. Metabolic parameters, inflammatory markers, and GLP levels will be measured and recorded.
- Serum cortisol levels
- Serum GLP levels
- Ghrelin, leptin
- Calculation of HbA1C, glucose, insulin levels and HOMA IR
- Thyroid stimulating hormone (TSH) levels
- CRP levels
- Inflammatory panel (IL-1, IL-6 and TNF-a levels)
- B12, folic acid and ferritin levels
- Serum lipid profile (total cholesterol, LDL cholesterol, HDL cholesterol, triglyceride)
- Liver function tests
In addition to neuroanatomical and other biomarkers, investigating physicians will monitor the general clinical status of the patients and changes such as hypertension and sleep apnea will be noted. Nutritionists will also follow diet compliance of the patients. Daily mobility and exercise levels will also be assessed. All of these obtained markers will be used both longitudinally (0-3 and 12 months of obese individuals compared to each other) and comparison to healthy controls at the 0, 3 and 12 months. During the collection of imaging and biomarkers data, the control group will be monitored for 12 months as well.
Aim 5: To determine factors of eating, emotional regulation, reward system, addiction and impulsivity, and other psychopathologies that cause suboptimal weight loss or weight gain after bariatric surgery.
Similar to the previous methods, patients will fill in the self-assessment scales and apply cognitive tests on the computer via the assistance of Candan Yasemin Eren. The tests to be applied in this section will be the scales used to evaluate the environmental and psychiatric profile described in method 1, the PENN-CNP battery described in method 2, and the PRT batteries in method 3.
Study design
- Primary purpose
- Basic science
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- In this study, patients undergoing bariatric surgery will be assessed at baseline and after bariatric surgery. We intend to analyze the changes in this repeated and dependent measurements. The other group will be undisturbed during the follow up except for clinical assessments and MRI imaging.
| Arm | Type | Receives |
|---|---|---|
| Patients undergoing bariatric surgery | Experimental | Procedure: Bariatric surgeryIn this study, patients will undergo sleeve gastrectomy to reduce the size of the stomach to induce weight loss. |
| Control group | No intervention | –Healthy controls with normal BMI. |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (7 listed)
- Be between the ages of 18-65
- To be able to give informed consent
- Be a candidate for bariatric surgery.
- Be between the ages of 18-65
- To be able to give informed consent
Key exclusion criteria (9 listed)
- Dementia
- Individuals with severe mental retardation and marked cognitive impairments
- Psychotic disorders
- Psychoactive substance addiction diagnosis
- Dementia
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Bariatric surgeryIn this study, patients will undergo sleeve gastrectomy to reduce the size of the stomach to induce weight loss. | Procedure or surgery | Patients undergoing bariatric surgery |
Primary outcome
Changes in working memory following bariatric surgery
Time frame: Pre-surgery, 3rd and 12th months after bariatric surgery
Letter-and-Back Task in the PENN-CNP neuropsychological battery will be used to assess working memory. Letter-and-Back asks participants to focus on letters on the screen and press the spacebar according to certain rules. The task consists of three parts: 0-back, 1-back, 2-back. During 0-back, participants press the spacebar when they see letter "X" on the screen. During 1-back, participants press the spacebar when they see the same letter twice. During 2-back, participants press the spacebar when the letter on the screen is the same as the letter before the previous letter.
Grey-matter changes in the entire brain, focused assessments on brain areas known to be associated with cognitive functions
Time frame: MRI examination will be repeated both for the obese patient group and concurrently healthy controls before surgery (0 months) and after surgery at 3 and 12 months.
Structural and functional changes in the brain will be evaluated by magnetic resonance imaging (MRI). Thin-section T1-weighted images for evaluation of gray matter changes, resting functional magnetic resonance images for evaluation of functional changes will be obtained. For resting fMRI, patients will be asked to rest eyes closed for 6 minutes without thinking anything. Imaging will take approximately 30 minutes.
6 secondary outcomes
Changes in impulsivity following bariatric surgery
Time frame: Pre-surgery, 3rd and 12th months after bariatric surgery
Success of surgery
Time frame: 3rd and 12th months after bariatric surgery
Changes in inflammator factors following bariatric surgery
Time frame: Pre-surgery, 3rd and 12th months after bariatric surgery
Changes in GLP1 will be analyzed following bariatric surgery
Time frame: Pre-surgery, 3rd and 12th months after bariatric surgery
Changes in social cognition following bariatric surgery
Time frame: Pre-surgery, 3rd and 12th months after bariatric surgery
Changes in reward learning following bariatric surgery
Time frame: Pre-surgery, 3rd and 12th months after bariatric surgery
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 5 Oct 2023.
- Background: PubMed 26258159Admon R, Pizzagalli DA. Dysfunctional Reward Processing in Depression. Curr Opin Psychol. 2015 Aug 1;4:114-118. doi: 10.1016/j.copsyc.2014.12.011.
- Background: PubMed 21675347Alciati A, Gesuele F, Rizzi A, Sarzi-Puttini P, Foschi D. Childhood parental loss and bipolar spectrum in obese bariatric surgery candidates. Int J Psychiatry Med. 2011;41(2):155-71. doi: 10.2190/PM.41.2.e.
- Background: PubMed 22814127Zeki Al Hazzouri A, Haan MN, Whitmer RA, Yaffe K, Neuhaus J. Central obesity, leptin and cognitive decline: the Sacramento Area Latino Study on Aging. Dement Geriatr Cogn Disord. 2012;33(6):400-9. doi: 10.1159/000339957. Epub 2012 Jul 17.
- Background: PubMed 25628737Alosco ML, Spitznagel MB, Strain G, Devlin M, Cohen R, Crosby RD, Mitchell JE, Gunstad J. Improved serum leptin and ghrelin following bariatric surgery predict better postoperative cognitive function. J Clin Neurol. 2015 Jan;11(1):48-56. doi: 10.3988/jcn.2015.11.1.48. Epub 2015 Jan 2.
- Background: PubMed 23625587Alosco ML, Spitznagel MB, Strain G, Devlin M, Cohen R, Paul R, Crosby RD, Mitchell JE, Gunstad J. Improved memory function two years after bariatric surgery. Obesity (Silver Spring). 2014 Jan;22(1):32-8. doi: 10.1002/oby.20494. Epub 2013 Oct 15.
- Background: PubMed 21348917Anstey KJ, Cherbuin N, Budge M, Young J. Body mass index in midlife and late-life as a risk factor for dementia: a meta-analysis of prospective studies. Obes Rev. 2011 May;12(5):e426-37. doi: 10.1111/j.1467-789X.2010.00825.x. Epub 2011 Feb 23.
- Background: PubMed 27400415Bak M, Seibold-Simpson SM, Darling R. The potential for cross-addiction in post-bariatric surgery patients: Considerations for primary care nurse practitioners. J Am Assoc Nurse Pract. 2016 Dec;28(12):675-682. doi: 10.1002/2327-6924.12390. Epub 2016 Jul 11.
- Background: PubMed 8592650Bellinger FP, Madamba SG, Campbell IL, Siggins GR. Reduced long-term potentiation in the dentate gyrus of transgenic mice with cerebral overexpression of interleukin-6. Neurosci Lett. 1995 Sep 29;198(2):95-8. doi: 10.1016/0304-3940(95)11976-4.
- Background: PubMed 28159563Bergmann KL, Cox SJ, Tabone LE. Influence of a rural environment on patient access and outcomes for bariatric surgery. Surg Obes Relat Dis. 2017 Apr;13(4):632-636. doi: 10.1016/j.soard.2016.11.009. Epub 2016 Nov 11.
- Background: PubMed 18207116Biessels GJ, Deary IJ, Ryan CM. Cognition and diabetes: a lifespan perspective. Lancet Neurol. 2008 Feb;7(2):184-90. doi: 10.1016/S1474-4422(08)70021-8.
- Background: PubMed 12119665Bjorntorp P. Do stress reactions cause abdominal obesity and comorbidities? Obes Rev. 2001 May;2(2):73-86. doi: 10.1046/j.1467-789x.2001.00027.x.
- Background: PubMed 23483116Blum K, Bailey J, Gonzalez AM, Oscar-Berman M, Liu Y, Giordano J, Braverman E, Gold M. Neuro-Genetics of Reward Deficiency Syndrome (RDS) as the Root Cause of "Addiction Transfer": A New Phenomenon Common after Bariatric Surgery. J Genet Syndr Gene Ther. 2011 Dec 23;2012(1):S2-001. doi: 10.4172/2157-7412.S2-001.
- Individual participant dataSharing planned: No
Related trials for Obesity
RecruitingObservational study
Endoscopic Sleeve Gastroplasty (ESG) Prospective Trial for Obesity (EGO-Trial)
Obesity
Active, not recruitingPhase 4
Effects of Sequential Therapy With Mexidol® (Intravenous) and Mexidol® FORTE 250 (Oral) on Functional Brain Activity Assessed by Functional Magnetic Resonance Imaging and Biochemical Parameters in Patients With Chronic Cerebral Ischemia: A Comparison of Patients With and Without Metabolic Disorders
Metabolic Abnormalities, Obesity & Overweight
Recruiting
Exercise Training and Vitamin D Metabolism
Obesity & Overweight, Vitamin D
Recruiting
Metabolic Health, Bones and Nuts During Weight Loss in Adults
Weight Loss, Bone Density
Active, not recruiting
Effect of Probiotics on Insulin Sensitivity in Overweight and Obese Pregnancy
Obesity & Overweight, Gestational Diabetes Mellitus (GDM)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Hale Yapici Eser, MD, PHD principal investigator
Koc University School of Medicine
3 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Bariatric surgery in people with Obesity and Cognitive Disorder, run by Koç University at 3 sites in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 5 Oct 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 3 sites in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Changes in working memory following bariatric surgery (time frame: Pre-surgery, 3rd and 12th months after bariatric surgery). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03528044, which also lists 85 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Oct 2023.